Alcohol consumption and the use of antidepressants

CMAJ. Canadian Medical Association Journal

Volumn 176, Issue 5, 2007, Pages 633-637

  Graham, Kathryn ^a,b   Massak, Agnes ^a  

^a UNIVERSITY OF WESTERN ONTARIO   (Canada)

^b CENTRE FOR ADDICTION AND MENTAL HEALTH   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; FLUOXETINE; PAROXETINE; VENLAFAXINE;

ADULT; AGED; ALCOHOL CONSUMPTION; ARTICLE; CONTROLLED STUDY; DEPRESSION; DRINKING BEHAVIOR; FEMALE; HEALTH SURVEY; HUMAN; HUMAN EXPERIMENT; INFORMATION SERVICE; INTERVIEW; MAJOR DEPRESSION; MALE; PSYCHOSOCIAL ENVIRONMENT; WORLD HEALTH ORGANIZATION;

EID: 33947232773     PISSN: 08203946     EISSN: 14882329     Source Type: Journal    
DOI: 10.1503/cmaj.060446     Document Type: Article

References (31)

1. Rodgers B, Korten AE, Jorm AF, et al. Risk factors for depression and anxiety in abstainers, moderate drinkers and heavy drinkers. Addiction 2000;95:1833-45.
2. Lipton R. The relationship between alcohol, stress, and depression in Mexican American and Non-Hispanic Whites. Behav Med 1997;23:101-11.
3. Patten SB, Charney DA. Alcohol consumption and major depression in the Canadian population. Can J Psychiatry 1998;43:502-6.
4. Gilman SE, Abraham HD. A longitudinal study of the order of onset of alcohol dependence and major depression. Drug Alcohol Depend 2001;63:277-86.
5. Grant BF, Harford TC. Comorbidity between DSM-IV alcohol use disorders and major depression: results of a national survey. Drug Alcohol Depend 1995;39:197-206.
6. Hartka E, Johnstone B, Leino EV, et al. A meta-analysis of depressive symptomatology over time. Br J Addict 1991;86:1283-98
7. Caldwell TM, Rodgers B, Jorm AF, et al. Patterns of association between alcohol consumption and symptoms of depression and anxiety in young adults. Addiction 2002;97:583-94.
8. Virkkunen M, Linnoila M. Serotonin in early-onset alcoholism. Recent Dev Alcohol 1997;13:173-91.
9. Ramsey SE, Engler PA, Stein MD. Alcohol use among depressed patients: the need for assessment and intervention. Prof Psychol Res Pract 2005;36:203-7.
10. Weathermen R, Crabb DW. Alcohol and medication interactions. Alcohol Res Health 1999;23:40-54.
11. Torrens M, Fonseca F, Mateu G, et al. Efficacy of antidepressants in substance use disorders with and without comorbid depression: a systematic review and metaanalysis. Drug Alcohol Depend 2005;78:1-22.
12. Nunes EV, Levin FR. Treatment of depression in patients with alcohol or other drug dependence, a meta-analysis. JAMA 2004;291:1887-96.
13. Naranjo CA, Knoke DM. The role of selective serotonin reuptake inhibitors in reducing alcohol consumption. J Clin Psychiatry 2001;62(Suppl 20)118-25.
14. Babor TF, Hofmann M, DelBoca FK, et al. Types of alcoholics, I. Evidence for an empirically derived typology based on indicators of vulnerability and severity. Arch Gen Psychiatry 1992;49:599-608.
15. Kranzler HR, Burleson JA, Brown J, et al. Fluoxetine treatment seems to reduce the beneficial effects of cognitive-behavioral therapy in Type B alcoholics. Alcohol Clin Exp Res 1996;20:1534-41.
16. Dundon W, Lynch KG, Pettinati HM, et al. Treatment outcomes in Type A and B alcohol dependence 6 months after serontonergic pharmacotherapy. Alcohol Clin Exp Res 2004;28:1065-73.
17. Pettinati HM, Volpicelli JR, Kranzler HR, et al. Sertraline treatment for alcohol dependence: interactive effects of medication and alcoholic subtype. Alcohol Clin Exp Res 2000;24:1041-9.
18. Chick J, Aschauer H, Hornik K; Investigators Group. Efficacy of fluvoxamine in preventing relapse in alcohol dependence: a one-year, double-blind, placebo-controlled multicentre study with analysis by typology. Drug Alcohol Depend 2004;74:61-70.
19. Rehm J, Room R, Monteiro M, et al. Alcohol use. In: Ezzati M, Lopez AD, Rodgers A, Murray CJL (eds.). Comparative quantification of health risks: global and regional burden of disease attributable to selected major risk factors. Geneva: WHO; 2004. p. 959-110.
20. Cho YI, Johnson TP, Fendrich M. Monthly variations in self-reports of alcohol consumption. J Stud Alcohol 2001;62:268-72.
21. McAuliffe WE, Geller S, LaBrie R, et al. Are telephone surveys suitable for studying substance abuse? Cost, administration, coverage and response rate issues. J Drug Issues 1998;28:455-82.
22. Midanik LT., Greenfield TK, Rogers JD. Reports of alcohol-related harm: telephone versus face-to-face interviews. J Stud Alcohol 2001;62:74-8.
23. Adlaf EM, Rehm J. Survey design and methodology. In: Adlaf EM, Begin P, Sawka E, editors. Canadian Addiction Survey (CAS). Detailed Report. Ottawa: Canadian Centre on Substance Abuse. 2005. p. 11-19.
24. Wittchen H-U, Robins LN, Cottler LB, et al. Cross-cultural feasibility, reliability and sources of variance of the Composite International Diagnostic Interview (CIDI). Br J Psychiatry 1991;159:645-53.
25. Saunders JB, Aasland OG, Babor TF, et al. Development of the Alcohol Use Disorders Identification Test (AUDIT): WHO collaborative project on early detection of persons with harmful alcohol consumption-II. Addiction 1993;88:791-804
26. Bondy SJ, Rehm J, Ashley MJ, et al. Low-risk drinking guidelines: the scientific evidence. Can J Public Health 1999;90:264-70.
27. Babor TF, Higgins-Biddle JC, Saunders JB, et al. AUDIT: The Alcohol Use Disorders Identification Test: guidelines for use in primary care. Geneva: World Health Organization; 2001.
28. Rosenwasser AM. Alcohol, antidepressants, and circadian rhythms. Human and animal models. Alcohol Res Health 2001;25:126-35.
29. Babor TF, Higgins-Biddle JC. Alcohol screening and brief intervention: dissemination strategies for medical practice and public health. Addiction 2000;95:677-86.
30. Roeloffs CA, Fink A, Unutzer J, et al. Problematic substance use, depressive symptoms, and gender in primary care. Psychiatr Serv 2001;52:1251-3.
31. Kahan M, Wilson L, Becker L. Effectiveness of physician-based interventions with problem drinkers: a review. CMAJ 1995;152:851-9.